Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Expression in Squamous Cell Carcinomas of the Head and Neck
- 1 October 2001
- journal article
- research article
- Published by Wiley in The Laryngoscope
- Vol. 111 (10) , 1834-1841
- https://doi.org/10.1097/00005537-200110000-00031
Abstract
Objectives Vascular endothelial growth factor receptor 2 (VEGFR2; Flk-1 [fetal liver kinase]/KDR [kinase insert domain containing receptor]) has been identified as a high affinity receptor for vascul...Keywords
This publication has 37 references indexed in Scilit:
- Tumor angiogenesis - a new therapeutic target in gliomasActa Neurologica Scandinavica, 2009
- Role of vascular endothelial growth factor in the regulation of angiogenesisKidney International, 1999
- Vascular endothelial growth factor (VEGF) and its receptorsThe FASEB Journal, 1999
- Vascular Endothelial Growth Factor (VEGF) and Microvessel Density in Squamous Cell Carcinomas of the Larynx: an Immunohistochemical StudyActa Oto-Laryngologica, 1999
- New perspectives in clinical oncology from angiogenesis researchEuropean Journal Of Cancer, 1996
- Influence of Microvessel Density and Vascular Permeability Factor/Vascular Endothelial Growth Factor Expression on Prognosis in Vulvar CancerGynecologic Oncology, 1996
- Tumor angiogenesis: A physiological process or genetically determined?Cancer and Metastasis Reviews, 1996
- Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factorCancer and Metastasis Reviews, 1996
- The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progressionBreast Cancer Research and Treatment, 1995
- Angiogenesis and colonization in the tumor metastatic process: basic and applied advancesThe FASEB Journal, 1994